Developments in Biopharmaceutical LC-MS Methods Increase Selectivity

4 August 2016

Find out how LGC are developing biopharmaceutical LC-MS methods to support preclinical and clinical studies. Kjetil Hansen, Scientist in the Bioanalysis department within Drug Development Services, discusses the benefits of using LC-MS methods over traditional immunoassay techniques, using the Waters SYNAPT G2 QTof and Xevo TQ-S.